Loading…
Combination of Imvotamab and Loncastuximab Tesirine Shows Enhanced Anti‐Tumor Activity in a Preclinical Model of Non‐Hodgkin’s Lymphoma
Saved in:
| Published in: | Hematological oncology 2023-06, Vol.41 (S2), p.552-553 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c1924-2377195da1142dd215e342e7c1ef327f65c0175d478c61315ddee67320b9bc063 |
|---|---|
| cites | |
| container_end_page | 553 |
| container_issue | S2 |
| container_start_page | 552 |
| container_title | Hematological oncology |
| container_volume | 41 |
| creator | Logronio, K. A. Joglekar, M. Oyasu, M. Yakkundi, P. Leabman, M. K. Hernandez, G. Manley, T. Sinclair, A. M. Carroll, S. F. Candia, A. Keyt, B. A. Kotturi, M. F. |
| description | |
| doi_str_mv | 10.1002/hon.3164_413 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3089978994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3089978994</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1924-2377195da1142dd215e342e7c1ef327f65c0175d478c61315ddee67320b9bc063</originalsourceid><addsrcrecordid>eNp9kM1KAzEUhYMoWKs7HyDg1qn5mZl0lqWoFaoVrOuQJhkbnUlqMtPanS8guPX1fBIzVLcuLuf-fNwDB4BTjAYYIXKxdHZAcZ7yFNM90MOoKBKM8mIf9BBhwwQRSg7BUQjPCMUbGvbAx9jVC2NFY5yFroQ39do1ohYLKKyCU2elCE37ZrrNXAfjjdXwYek2AV7apbBSKziyjfl-_5y3tfNwJBuzNs0WGgsFvPdaVsYaKSp465SuOo87ZyM-cerpxcTuK8Dptl4tXS2OwUEpqqBPfrUPHq8u5-NJMp1d34xH00TigqQJoYzhIlMC45QoRXCmaUo0k1iXlLAyzyTCLFMpG8ocU5wppXXOKEGLYiFRTvvgbPd35d1rq0PDn13rbbTkFA2LgsVKI3W-o6R3IXhd8pWPQfgtx4h3gfMYOP8LPOLZDt-YSm__ZflkdtdJN9MftJaHxw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3089978994</pqid></control><display><type>article</type><title>Combination of Imvotamab and Loncastuximab Tesirine Shows Enhanced Anti‐Tumor Activity in a Preclinical Model of Non‐Hodgkin’s Lymphoma</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Logronio, K. A. ; Joglekar, M. ; Oyasu, M. ; Yakkundi, P. ; Leabman, M. K. ; Hernandez, G. ; Manley, T. ; Sinclair, A. M. ; Carroll, S. F. ; Candia, A. ; Keyt, B. A. ; Kotturi, M. F.</creator><creatorcontrib>Logronio, K. A. ; Joglekar, M. ; Oyasu, M. ; Yakkundi, P. ; Leabman, M. K. ; Hernandez, G. ; Manley, T. ; Sinclair, A. M. ; Carroll, S. F. ; Candia, A. ; Keyt, B. A. ; Kotturi, M. F.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.3164_413</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Lymphoma</subject><ispartof>Hematological oncology, 2023-06, Vol.41 (S2), p.552-553</ispartof><rights>2023 The Authors. Hematological Oncology published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1924-2377195da1142dd215e342e7c1ef327f65c0175d478c61315ddee67320b9bc063</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Logronio, K. A.</creatorcontrib><creatorcontrib>Joglekar, M.</creatorcontrib><creatorcontrib>Oyasu, M.</creatorcontrib><creatorcontrib>Yakkundi, P.</creatorcontrib><creatorcontrib>Leabman, M. K.</creatorcontrib><creatorcontrib>Hernandez, G.</creatorcontrib><creatorcontrib>Manley, T.</creatorcontrib><creatorcontrib>Sinclair, A. M.</creatorcontrib><creatorcontrib>Carroll, S. F.</creatorcontrib><creatorcontrib>Candia, A.</creatorcontrib><creatorcontrib>Keyt, B. A.</creatorcontrib><creatorcontrib>Kotturi, M. F.</creatorcontrib><title>Combination of Imvotamab and Loncastuximab Tesirine Shows Enhanced Anti‐Tumor Activity in a Preclinical Model of Non‐Hodgkin’s Lymphoma</title><title>Hematological oncology</title><subject>Lymphoma</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kM1KAzEUhYMoWKs7HyDg1qn5mZl0lqWoFaoVrOuQJhkbnUlqMtPanS8guPX1fBIzVLcuLuf-fNwDB4BTjAYYIXKxdHZAcZ7yFNM90MOoKBKM8mIf9BBhwwQRSg7BUQjPCMUbGvbAx9jVC2NFY5yFroQ39do1ohYLKKyCU2elCE37ZrrNXAfjjdXwYek2AV7apbBSKziyjfl-_5y3tfNwJBuzNs0WGgsFvPdaVsYaKSp465SuOo87ZyM-cerpxcTuK8Dptl4tXS2OwUEpqqBPfrUPHq8u5-NJMp1d34xH00TigqQJoYzhIlMC45QoRXCmaUo0k1iXlLAyzyTCLFMpG8ocU5wppXXOKEGLYiFRTvvgbPd35d1rq0PDn13rbbTkFA2LgsVKI3W-o6R3IXhd8pWPQfgtx4h3gfMYOP8LPOLZDt-YSm__ZflkdtdJN9MftJaHxw</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Logronio, K. A.</creator><creator>Joglekar, M.</creator><creator>Oyasu, M.</creator><creator>Yakkundi, P.</creator><creator>Leabman, M. K.</creator><creator>Hernandez, G.</creator><creator>Manley, T.</creator><creator>Sinclair, A. M.</creator><creator>Carroll, S. F.</creator><creator>Candia, A.</creator><creator>Keyt, B. A.</creator><creator>Kotturi, M. F.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>202306</creationdate><title>Combination of Imvotamab and Loncastuximab Tesirine Shows Enhanced Anti‐Tumor Activity in a Preclinical Model of Non‐Hodgkin’s Lymphoma</title><author>Logronio, K. A. ; Joglekar, M. ; Oyasu, M. ; Yakkundi, P. ; Leabman, M. K. ; Hernandez, G. ; Manley, T. ; Sinclair, A. M. ; Carroll, S. F. ; Candia, A. ; Keyt, B. A. ; Kotturi, M. F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1924-2377195da1142dd215e342e7c1ef327f65c0175d478c61315ddee67320b9bc063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Lymphoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Logronio, K. A.</creatorcontrib><creatorcontrib>Joglekar, M.</creatorcontrib><creatorcontrib>Oyasu, M.</creatorcontrib><creatorcontrib>Yakkundi, P.</creatorcontrib><creatorcontrib>Leabman, M. K.</creatorcontrib><creatorcontrib>Hernandez, G.</creatorcontrib><creatorcontrib>Manley, T.</creatorcontrib><creatorcontrib>Sinclair, A. M.</creatorcontrib><creatorcontrib>Carroll, S. F.</creatorcontrib><creatorcontrib>Candia, A.</creatorcontrib><creatorcontrib>Keyt, B. A.</creatorcontrib><creatorcontrib>Kotturi, M. F.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Logronio, K. A.</au><au>Joglekar, M.</au><au>Oyasu, M.</au><au>Yakkundi, P.</au><au>Leabman, M. K.</au><au>Hernandez, G.</au><au>Manley, T.</au><au>Sinclair, A. M.</au><au>Carroll, S. F.</au><au>Candia, A.</au><au>Keyt, B. A.</au><au>Kotturi, M. F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combination of Imvotamab and Loncastuximab Tesirine Shows Enhanced Anti‐Tumor Activity in a Preclinical Model of Non‐Hodgkin’s Lymphoma</atitle><jtitle>Hematological oncology</jtitle><date>2023-06</date><risdate>2023</risdate><volume>41</volume><issue>S2</issue><spage>552</spage><epage>553</epage><pages>552-553</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.3164_413</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2023-06, Vol.41 (S2), p.552-553 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_3089978994 |
| source | Wiley-Blackwell Read & Publish Collection |
| subjects | Lymphoma |
| title | Combination of Imvotamab and Loncastuximab Tesirine Shows Enhanced Anti‐Tumor Activity in a Preclinical Model of Non‐Hodgkin’s Lymphoma |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A04%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combination%20of%20Imvotamab%20and%20Loncastuximab%20Tesirine%20Shows%20Enhanced%20Anti%E2%80%90Tumor%20Activity%20in%20a%20Preclinical%20Model%20of%20Non%E2%80%90Hodgkin%E2%80%99s%20Lymphoma&rft.jtitle=Hematological%20oncology&rft.au=Logronio,%20K.%20A.&rft.date=2023-06&rft.volume=41&rft.issue=S2&rft.spage=552&rft.epage=553&rft.pages=552-553&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.3164_413&rft_dat=%3Cproquest_cross%3E3089978994%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1924-2377195da1142dd215e342e7c1ef327f65c0175d478c61315ddee67320b9bc063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3089978994&rft_id=info:pmid/&rfr_iscdi=true |